학술논문
Efficacy and Safety of Tyrosine Kinase Inhibitors in the Treatment of Relapsed/Refractory Immune Thrombocytopenia
Document Type
Abstract
Author
Source
In Blood 15 November 2022 140 Supplement 1:8408-8409
Subject
Language
ISSN
0006-4971